Mbiotech to distribute Gene Bridges Recombineering Technology in Korea

22-Feb-2008

Gene Bridges GmbH announced that Mbiotech will distribute Gene Bridges' patented Red/ET recombination technology in Korea. Mbiotech was selected due to its expertise producing and marketing a wide range of molecular biology reagents.

Under the terms of the agreement, Mbiotech will be the exclusive source of recombineering kits and reagents for the Korean the biotech community.

Mbiotech is a privately owned manufacturing and distribution company located in Seoul, Korea. The Company specialises in manufacturing a range of products including protein markers, DNA markers, Taq DNA polymerase and Nucleic Acid purification kits. Mbiotech distributes their products worldwide, using a variety of different companies and channels.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances